974 related articles for article (PubMed ID: 19131449)
1. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia.
Chalmers JD; Singanayagam A; Murray MP; Scally C; Fawzi A; Hill AT
Thorax; 2009 Jul; 64(7):592-7. PubMed ID: 19131449
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein is an independent predictor of severity in community-acquired pneumonia.
Chalmers JD; Singanayagam A; Hill AT
Am J Med; 2008 Mar; 121(3):219-25. PubMed ID: 18328306
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors, microbiology and outcome of patients with parapneumonic effusion.
Falguera M; Carratalà J; Bielsa S; García-Vidal C; Ruiz-González A; Chica I; Gudiol F; Porcel JM
Eur Respir J; 2011 Nov; 38(5):1173-9. PubMed ID: 21565916
[TBL] [Abstract][Full Text] [Related]
4. Prior statin use is associated with improved outcomes in community-acquired pneumonia.
Chalmers JD; Singanayagam A; Murray MP; Hill AT
Am J Med; 2008 Nov; 121(11):1002-1007.e1. PubMed ID: 18954848
[TBL] [Abstract][Full Text] [Related]
5. [CCERW: a new rule to predict treatment failure in patients with community-acquired pneumonia in middle aged and elderly people].
Li JS; Li SY; Yu XQ; Sun ZK; Zhang W; Jia XH; Zheng SP; Wang MH; Wang HF
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Jan; 23(1):10-7. PubMed ID: 21251359
[TBL] [Abstract][Full Text] [Related]
6. Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia.
Chalmers JD; Singanayagam A; Hill AT
Thorax; 2008 Aug; 63(8):698-702. PubMed ID: 18492742
[TBL] [Abstract][Full Text] [Related]
7. Development of parapneumonic empyema in children.
Lahti E; Peltola V; Virkki R; Alanen M; Ruuskanen O
Acta Paediatr; 2007 Nov; 96(11):1686-92. PubMed ID: 17888048
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing length of hospital stay in patients with bacterial pleural effusion.
Soriano T; Alegre J; Alemán C; Ruiz E; Vázquez A; Carrasco JL; Segura R; Ferrer A; Fernández de Sevilla T
Respiration; 2005; 72(6):587-93. PubMed ID: 16106111
[TBL] [Abstract][Full Text] [Related]
9. Pneumonia with pleural effusions.
Limthongkul S; Charoenlap P; Wongthim S; Udompanich V; Nuchprayoon C
J Med Assoc Thai; 1994 May; 77(5):225-30. PubMed ID: 7869002
[TBL] [Abstract][Full Text] [Related]
10. Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients.
Menéndez R; Torres A; Rodríguez de Castro F; Zalacaín R; Aspa J; Martín Villasclaras JJ; Borderías L; Benítez Moya JM; Ruiz-Manzano J; Blanquer J; Pérez D; Puzo C; Sánchez-Gascón F; Gallardo J; Alvarez CJ; Molinos L;
Clin Infect Dis; 2004 Dec; 39(12):1783-90. PubMed ID: 15578400
[TBL] [Abstract][Full Text] [Related]
11. Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001.
Buckingham SC; King MD; Miller ML
Pediatr Infect Dis J; 2003 Jun; 22(6):499-504. PubMed ID: 12799505
[TBL] [Abstract][Full Text] [Related]
12. Predicting Complicated Parapneumonic Effusion in Community Acquired Pneumonia: Hospital Based Case-Control Study.
P M; Awasthi S
Indian J Pediatr; 2019 Feb; 86(2):140-147. PubMed ID: 30182278
[TBL] [Abstract][Full Text] [Related]
13. Complicated parapneumonic effusion and empyema thoracis: microbiology and predictors of adverse outcomes.
Tsang KY; Leung WS; Chan VL; Lin AW; Chu CM
Hong Kong Med J; 2007 Jun; 13(3):178-86. PubMed ID: 17548905
[TBL] [Abstract][Full Text] [Related]
14. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions.
Porcel JM; Galindo C; Esquerda A; Trujillano J; Ruiz-González A; Falguera M; Vives M
Respirology; 2008 Jan; 13(1):58-62. PubMed ID: 18197912
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes.
Cillóniz C; Ewig S; Polverino E; Muñoz-Almagro C; Marco F; Gabarrús A; Menéndez R; Mensa J; Torres A
Clin Microbiol Infect; 2012 Nov; 18(11):1134-42. PubMed ID: 22044658
[TBL] [Abstract][Full Text] [Related]
16. Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study.
Misthos P; Sepsas E; Konstantinou M; Athanassiadi K; Skottis I; Lioulias A
Eur J Cardiothorac Surg; 2005 Oct; 28(4):599-603. PubMed ID: 16129614
[TBL] [Abstract][Full Text] [Related]
17. Radiographic, clinical, and prognostic features of complicated and uncomplicated community-acquired lobar pneumonia in children.
Lin CJ; Chen PY; Huang FL; Lee T; Chi CS; Lin CY
J Microbiol Immunol Infect; 2006 Dec; 39(6):489-95. PubMed ID: 17164952
[TBL] [Abstract][Full Text] [Related]
18. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].
Christ-Crain M; Morgenthaler NG; Stolz D; Müller C; Bingisser R; Harbarth S; Tamm M; Struck J; Bergmann A; Müller B
Crit Care; 2006; 10(3):R96. PubMed ID: 16805922
[TBL] [Abstract][Full Text] [Related]
19. Lower incidence of acute respiratory distress syndrome in community-acquired pneumonia patients aged 85 years or older.
Toba A; Yamazaki M; Mochizuki H; Noguchi T; Tsuda Y; Kawate E; Suzuki Y; Takahashi H
Respirology; 2010 Feb; 15(2):319-25. PubMed ID: 20070586
[TBL] [Abstract][Full Text] [Related]
20. The significance of parapneumonic pleural effusions developing during antibiotic treatment for pneumonia.
Macrea M; Metersky ML
Conn Med; 2006; 70(6):371-5. PubMed ID: 16869468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
